VLP Therapeutics, Inc. (VLPT) researchers and their colleagues at Stanford University and the University of North Carolina at Chapel Hill reported their findings online ahead of print in the Journal of Controlled Release, a peer-reviewed medical journal with an impact factor of 10.5 published by Elsevier. Stanford took the lead in this collaborative work.
- Title: Lyophilized SARS-CoV-2 self-amplifying RNA vaccines for microneedle Array patch delivery
- Journal: Journal of Controlled Release
- Authors: Madison M Driskill, Ian A Coates, Paul J Hurst, Netra U Rajesh, Maria T Dulay, Robert M Waymouth, Wataru Akahata, Kenta Matsuda, Jonathan F Smith, Gunilla B Jacobson, Jillian L Perry, Shaomin Tian*, Joseph M DeSimone* (*Corresponding authors)
- DOI: 10.1016/j.jconrel.2025.113944
- URL: https://www.sciencedirect.com/science/article/abs/pii/S0168365925005644
- Published: June 9, 2025